IRIS
HEFFLER, Enrico Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.237
AS - Asia 7.954
EU - Europa 3.206
SA - Sud America 1.683
AF - Africa 415
Continente sconosciuto - Info sul continente non disponibili 265
OC - Oceania 49
AN - Antartide 1
Totale 26.810
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.861
SG - Singapore 4.821
BR - Brasile 1.381
CN - Cina 1.181
IT - Italia 933
VN - Vietnam 771
DE - Germania 448
FI - Finlandia 407
IE - Irlanda 318
HK - Hong Kong 271
NG - Nigeria 263
FR - Francia 214
CA - Canada 200
GB - Regno Unito 191
IN - India 183
NL - Olanda 155
AR - Argentina 116
MX - Messico 101
BD - Bangladesh 96
SE - Svezia 91
RU - Federazione Russa 78
TR - Turchia 77
ID - Indonesia 70
IQ - Iraq 59
ZA - Sudafrica 53
BE - Belgio 51
TW - Taiwan 51
EC - Ecuador 49
JP - Giappone 48
ES - Italia 47
KR - Corea 45
AU - Australia 42
CZ - Repubblica Ceca 41
PK - Pakistan 39
CO - Colombia 38
MY - Malesia 37
PL - Polonia 37
UA - Ucraina 34
VE - Venezuela 33
CH - Svizzera 28
IL - Israele 26
CL - Cile 25
AT - Austria 24
SA - Arabia Saudita 23
JO - Giordania 22
MA - Marocco 22
PY - Paraguay 17
UZ - Uzbekistan 16
DZ - Algeria 15
EG - Egitto 15
RO - Romania 15
AE - Emirati Arabi Uniti 13
NP - Nepal 13
PH - Filippine 13
AZ - Azerbaigian 12
KE - Kenya 12
PT - Portogallo 12
CR - Costa Rica 11
JM - Giamaica 11
PE - Perù 11
LT - Lituania 10
TN - Tunisia 10
UY - Uruguay 10
AL - Albania 9
GT - Guatemala 8
IR - Iran 8
KZ - Kazakistan 8
TH - Thailandia 8
NO - Norvegia 7
SN - Senegal 7
DK - Danimarca 6
ET - Etiopia 6
HR - Croazia 6
NI - Nicaragua 6
TT - Trinidad e Tobago 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BA - Bosnia-Erzegovina 5
BG - Bulgaria 5
GR - Grecia 5
HN - Honduras 5
KG - Kirghizistan 5
LB - Libano 5
NZ - Nuova Zelanda 5
OM - Oman 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
BB - Barbados 4
DO - Repubblica Dominicana 4
HU - Ungheria 4
LV - Lettonia 4
MD - Moldavia 4
PR - Porto Rico 4
PS - Palestinian Territory 4
SI - Slovenia 4
SV - El Salvador 4
AM - Armenia 3
BH - Bahrain 3
CI - Costa d'Avorio 3
EE - Estonia 3
GM - Gambi 3
Totale 26.508
Salva come PNG Salva come JPEG
Città #
Singapore 1.994
Chandler 1.325
Wilmington 1.291
Dallas 851
Ashburn 810
The Dalles 733
San Jose 556
San Mateo 482
Shanghai 457
Ann Arbor 416
Council Bluffs 412
Helsinki 402
New York 302
Dublin 297
Milan 280
Ho Chi Minh City 276
Boardman 260
Benin City 259
Beijing 252
Princeton 252
Hong Kong 238
Lawrence 235
Santa Clara 232
Leawood 221
Los Angeles 192
Hanoi 168
São Paulo 127
Fairfield 126
Falkenstein 125
Paris 125
Rome 118
Woodbridge 107
Amsterdam 106
Buffalo 91
Toronto 84
Phoenix 77
London 69
Seattle 58
Orem 46
Columbus 42
San Diego 42
Chicago 41
Munich 40
Rio de Janeiro 40
Haiphong 39
Brooklyn 38
Da Nang 38
Philadelphia 38
Naples 37
Belo Horizonte 36
Houston 34
Redwood City 34
Mexico City 33
Brussels 32
Norwalk 31
Kocaeli 30
Miami 30
Charlotte 29
Pune 29
Turin 29
Boston 28
Menlo Park 28
Warsaw 28
Atlanta 25
Newark 25
Tokyo 25
Curitiba 24
Denver 24
Frankfurt am Main 24
Brasília 23
Figino 23
Johannesburg 23
Mumbai 23
San Francisco 23
Campinas 22
Montreal 22
Baghdad 21
Chennai 21
Monmouth Junction 21
Queens 21
Brno 20
Stockholm 20
Guayaquil 19
Jakarta 19
Amman 18
Porto Alegre 17
Salvador 17
Falls Church 16
Can Tho 14
Dongguan 14
Florence 14
Genoa 14
Hyderabad 14
Nuremberg 14
Ottawa 14
Birmingham 13
Des Moines 13
Goiânia 13
Guarulhos 13
Kuala Lumpur 13
Totale 15.977
Salva come PNG Salva come JPEG
Nome #
The 10th anniversary of the Junior Members and Affiliates of the European Academy of Allergy and Clinical Immunology. 767
Multi-strain Symbiotic Preparations as a Novel Adjuvant Approach to Allergic Rhinitis 401
Probiotics as a Novel Adjuvant Approach to Atopic Dermatitis 308
Olfactory impairment in Italian patients with chronic rhinosinusitis with nasal polyps: a patient-centered survey 197
NAPPREB study protocol: A pivotal clinical trial to investigate clinical efficacy and potential response biomarkers to Benralizumab treatment in chronic rhinosinusitis with nasal polyps 170
"Characteristics of patients admitted to emergency department for asthma attack: a real-LIFE study". 166
A critical appraisal on AIT in childhood asthma. 161
Research needs in allergy: an EAACI position paper, in collaboration with EFA 155
Multiple Drug Allergy Due to Hypersensitivity to Polyethylene Glycols of Various Molecular Weights 149
Allergy in severe asthma. 140
Very rapid improvement of extended nitric oxide parameters, associated with clinical and functional betterment, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with Dupilumab 138
Macrogol hypersensitivity reactions during cleansing preparation for colon endoscopy. 138
Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients. 137
Nasal Polyposis Quality of Life (NPQ): Development and Validation of the First Specific Quality of Life Questionnaire for Chronic Rhinosinusitis with Nasal Polyps 136
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry 134
Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model 130
Italian study on buckwheat allergy: prevalence and clinical features of buckwheat-sensitized patients in Italy 128
A Bloody Mess: An Unusual Case of Diffuse Alveolar Hemorrhage Because of Warfarin Overdose 128
Adherence issues related to sublingual immunotherapy as perceived by allergists. 127
Acute urticaria presenting in the emergency room of a general hospital 125
Allergic patients during the COVID-19 pandemic-Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey 122
The accuracy of the HemoCue WBC DIFF in assessing blood eosinophils depends on the clinical setting and medical condition 122
Exhaled nitric oxide measurements: correction equation to compare hand-held device to stationary analyzer 121
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: an Italian Multicenter Study. 121
Hypersensitivity to gelatin used as excipient for soft capsules of Ibuprofen 121
An academic allergy unit during COVID-19 pandemic in Italy. 120
A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian Multicenter Study. 119
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper. 118
Nasal nitric oxide concentration in suspected chronic rhinosinusitis 114
The Severe Asthma Network in Italy: Findings and Perspectives 111
Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps 110
Pertinence of requested allergy consultations for suspected food allergy/intolerance. A Junior Members working group of Italian Society of Allergy and Clinical Immunology (SIAIC) multicenter study. 109
Acute asthma management during SARS-CoV2-pandemic 2020 109
Treatable traits in chronic rhinosinusitis with nasal polyps 109
Allergy in internet 107
Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing 106
Clinical presentation at the onset of COVID-19 and allergic rhinoconjunctivitis 106
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry 105
Incidence of food anaphylaxis in Piemonte region (Italy): data from registry of Center for Severe Allergic Reactions. 105
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis 105
Level of exhaled nitric oxide during human anaphylaxis 104
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 103
Allergen immunotherapy and biologics in respiratory allergy: friends or foes? 103
Allergy to buckwheat: an emerging clinical problem. Clinical and laboratory analysis of 24 consecutive patients 102
Breath analysis in patients with end-stage renal disease: effect of haemodialysis 101
Alpha1-antitrypsin deficiency and asthma 101
Nasal cytology: Methodology with application to clinical practice and research. 100
Anisakis hypersensitivity in Italy: prevalence and clinical features: a multicenter study. 100
Evolving phenotypes to endotypes: is precision medicine achievable in asthma? 97
Unexpected visitor: “hidden” food allergens 96
Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy? 96
Asthma from immune pathogenesis to precision medicine 96
Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma 96
Strategies to reduce corticosteroid-related adverse events in asthma 95
Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets 94
Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment 94
Gene Environment Interactions in Respiratory Diseases – Protocol, Standard Operative Procedures and Questionnaires 94
Exhaled nitric oxide in asthma. 93
Oxidative stress and airway inflammation after allergen challenge evaluated by exhaled breath condensate analysis 93
Unexplained chronic cough and vitamin B-12 deficiency. 93
Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence" 93
Anaphylaxis after eating italian pizza containing buckwheat as the hidden allergen 92
Anaphylaxis after a horse bite 92
Pharmacoeconomic evaluation of oral corticosteroid adverse events in patients with severe asthma 92
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice 92
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 92
Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 92
Extended IgE profile based on an allergen macroarray: a novel tool for precision medicine in allergy diagnosis. 92
Community pharmacist's professional adaptation amid Covid-19 emergency: a national survey on Italian pharmacists 92
Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps 91
Prevalence of over-/misdiagnosis of asthma in patients referred to an allergy clinic. 90
Exhaled nitric oxide as a clinical biomarker for choosing biologics for severe asthma treatment. 90
Eosinophils Target Therapy for Severe Asthma: Critical Points 90
New drugs in early-stage clinical trials for allergic rhinitis 90
Warning nonrespiratory symptoms in asthma: catastrophic abdominal involvement in a case of Churg-Strauss syndrome 89
One year of mepolizumab. Efficacy and safety in real-life in Italy 89
Microarray Immunodiagnostics for Aeroallergens 88
The Patient-Centered Decision System as per the 4Ps of Precision Medicine 88
Appropriateness in allergic respiratory diseases health care in Italy: definitions and organizational aspects 88
Cross-Country Comparison of Demographic and Clinical Characteristics of Patients Managed in Severe Asthma Services Across UK, USA, Australia, South Korea, and Italy 88
Minimal clinically important difference for asthma endpoints: an expert consensus report 88
Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center 86
Epinephrine autoinjector prescription in food-allergic adults: symptom-based only or allergen-based also? An Italian multi-centre study 86
Clinical manifestations, co-sensitizations, and immunoblotting profiles of buckwheat-allergic patients. 86
Exhaled nitric oxide in persistent rhinitis with or without lower airway involvement: a review of the literature. 86
Nasal nitric oxide in patients with inherited retinal dystrophies. 85
Diagnostic classification of persistent rhinitis and its relationship to exhaled nitric oxide and asthma: a clinical study of a consecutive series of patients. 85
Validation of the Italian version of the Test of Adherence to Inhalers (TAI) 85
Interleukin-5 in the Pathophysiology of Severe Asthma 85
EAACI consensus statement for investigation of work-related asthma in non-specialized centres 85
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 85
Escaping the trap of allergic rhinitis. 84
Impact of asthma on bronchiectasis severity and risk of exacerbations 84
Is air pollution affecting the disease activity in patients with systemic lupus erythematosus? State of the art and a systematic literature review. 83
Exhaled breath condensate pH and cysteinyl leukotriens in patients with chronic cough secondary to acid gastroesophageal reflux 83
Exhaled nitric oxide as a marker of diseases 83
Bronchodilator response as a marker of poor asthma control 82
Long-lasting clinical, radiological and immunological remission of severe nasal polyposis by means of 'reboot' surgery. 82
Real-life studies of biologics used in asthma patients: key differences and similarities to trials 82
Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients 82
Totale 11.643
Salva come PNG Salva come JPEG
Categoria #
all - tutte 158.000
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.000
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.323 0 0 51 298 22 30 52 190 117 110 380 73
2022/20233.681 550 149 348 416 354 295 26 290 657 297 234 65
2023/20242.110 183 242 437 66 114 184 90 136 63 60 176 359
2024/20254.141 128 105 78 106 156 385 229 392 643 925 467 527
2025/202610.551 1.378 623 992 1.086 317 388 2.606 669 554 584 451 903
2026/20272.249 758 765 726 0 0 0 0 0 0 0 0 0
Totale 26.810